XML 25 R12.htm IDEA: XBRL DOCUMENT v3.22.2.2
Inventory
 9 Months Ended
Sep. 30, 2022
Inventory Disclosure [Abstract]  
Inventory Inventory
At September 30, 2022 and December 31, 2021, the Company’s inventory primarily related to ORLADEYO. Additionally, inventory included RAPIVAB and peramivir, which is manufactured for the Company’s partners.
The Company’s inventories consisted of the following (in thousands):
September 30, 2022December 31, 2021
Raw materials$8,419 $5,658 
Work-in-process15,364 9,669 
Finished goods3,481 709 
Total inventory$27,264 $16,036 
Reserves(245)(245)
Total inventory, net$27,019 $15,791